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Q fever is a zoonosis caused by the intracellular bacterium Coxiella burnetii. Both humoral and cellular immunity
are important in the host defence against intracellular bacteria. Little is known about the immune response to
C. burnetii infections in domestic ruminants even though these species are the major source of Q fever in humans.
To investigate the goat’s immune response we inoculated groups of pregnant goats via inhalation with a Dutch
outbreak isolate of C. burnetii. All animals were successfully infected. Phase 1 and Phase 2 IgM- and IgG-specific
antibodies were measured. Cellular immune responses were investigated by interferon-gamma, enzyme-linked
immunosorbent spot test (IFN-γ Elispot), lymphocyte proliferation test (LPT) and systemic cytokines. After two weeks
post inoculation (wpi), a strong anti-C. burnetii Phase 2 IgM and IgG antibody response was observed while the
increase in IgM anti-Phase 1 antibodies was less pronounced. IgG anti-Phase 1 antibodies started to rise at 6 wpi.
Cellular immune responses were observed after parturition. Our results demonstrated humoral and cellular immune
responses to C. burnetii infection in pregnant goats. Cell-mediated immune responses did not differ enough to
distinguish between Coxiella-infected and non-infected pregnant animals, whereas a strong-phase specific
antibody response is detected after 2 wpi. This humoral immune response may be useful in the early detection of
C. burnetii-infected pregnant goats.Introduction
Q fever is a zoonosis caused by Coxiella burnetii.
C. burnetii has a worldwide distribution except for New
Zealand [1]. The bacterium has a wide host range includ-
ing humans, terrestrial and marine mammals, birds and
reptiles [2,3]. The zoonotic impact of the disease has re-
cently been underlined by the Dutch Q fever outbreak in
which 4029 human cases were registered during the years
2007–2010 [4,5]. More than 40 000 people are assumed
to be infected [6]. In this outbreak, C. burnetii-infected
pregnant goats and sheep were the primary source of Q
fever in humans [7,8]. During parturition these animals
excrete high numbers of C. burnetii into the environ-
ment. Inhalation of C. burnetii-contaminated aerosols is
the main route of infection in humans and can result in
acute or chronic Q fever [9]. In the acute phase, humans
suffer from a flu-like, self-limiting disease, atypical* Correspondence: hendrikjan.roest@wur.nl
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reproduction in any medium, provided the orpneumonia or hepatitis. The chronic form of Q fever
may lead to life-threatening endocarditis.
C. burnetii is a Gram-negative, intracellular bacterium.
As in other Gram-negative bacteria (e.g. Brucella spp.
and Enterobacteriaceae spp.), two major phenotypes
(phases) of C. burnetii are recognised. Phase 1 of
C. burnetii corresponds with the smooth phase of other
Gram-negative bacteria and expresses full-length lipo-
polysaccharide (LPS) on its surface. Phase 2 corresponds
with the rough phase of Gram-negative bacteria and
lacks the O-antigenic region on its LPS [10]. Phase 1 is
highly virulent and able to replicate in natural hosts,
while Phase 2 Coxiella are considered avirulent and un-
able to replicate in immunocompetent animals [11,12].
The phase variation is interesting for the humoral im-
mune response after Coxiella infection in mice, guinea
pigs and humans. Following the inoculation of mice and
guinea pigs with C. burnetii Phase 1, antibodies that rec-
ognise both Phase 1 and Phase 2 C. burnetii are gener-
ated [11,12]. In humans, the detection of phase-specific
antibodies plays an important role in the diagnosis of
acute and chronic Q fever [13]. This has not been investi-
gated yet in goats, but is of importance specially intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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do not excrete C. burnetii during pregnancy and can
therefore not be detected via the excretion of the bacter-
ium [14]. Tools might be found that can help in the early
diagnosis of Q fever in (pregnant) goats and can provide
insights into the herd dynamics of Q fever infections,
similar to those already anticipated in cattle herds [15].
The role of cellular immunity in the host defence
against C. burnetii infections is not well established. In
mice it is suggested that T cells are particularly important
for the clearance of the bacterium after infection.
Interferon-gamma (IFN-γ) and tumour necrosis factor-
alpha (TNF-α) seem to be essential for the early control
of Coxiella proliferation [12]. Furthermore, in vitro studies
with human, peripheral blood, mononuclear cells indicate
specific stimulation of T cells by human, monocyte-
derived, dendritic cells (HMDCs) pulsed with C. burnetii
outer membrane protein Com1 [16]. Recently the value of
the interferon-gamma, enzyme-linked, immunosorbent
spot test, a diagnostic tests based on cellular immunity, in
the diagnosis of chronic Q fever in humans has also been
shown [17]. In pre-vaccination screening of humans, a
skin test is used to detect previously sensitised people so
as to avoid adverse reactions after Q fever vaccination in
these persons [18]. In cattle, a skin test with a diluted vac-
cine antigen has been suggested as a read out for a cellular
response in an attempt to assess the duration of immunity
after Q fever vaccination [19]. Cellular immune responses
after C. burnetii infection of domestic ruminants have not
been investigated, although this may provide potential
tools to investigate the pathogenesis of C. burnetii infection
in ruminants and to improve its diagnosis. In addition, the
vaccine efficacy in already infected hosts can probably be
improved if the cell-mediated immunity can be stimulated
with a new generation of vaccines.
The goal of the present study was to investigate the
humoral and cellular immune response in pregnant goats
after inoculation with the Dutch outbreak strain of
C. burnetii. The humoral immune response was mea-
sured by detecting anti-Phase 1 and anti-Phase 2 IgM- and
IgG-specific antibodies. Cellular immune responses were
measured with the interferon-gamma, enzyme-linked, im-
munosorbent spot test (IFN-γ Elispot) and the lymphocyte
proliferation test (LPT) as well as by measuring systemic
mRNA for different cytokines. Our results indicate a strong
phase-specific IgM and IgG antibody response during early
infection, whereas the cell- mediated immune response did
not differ much between the Coxiella-infected pregnant
goats and the non-infected animals.
Materials and methods
Inoculum
C. burnetii strain X09003262-001 was isolated from a
placenta of a dairy goat that aborted on a farm duringthe Q fever outbreak in the Netherlands. This has
previously been described [14]. In short, part of an
immunohistochemically confirmed C. burnetii-positive
placenta was crushed and filtered before inoculation
with a culture of Buffalo Green Monkey (BGM) cells
kept in culture medium without antibiotics (EMEM with
10% bovine serum albumin, 1% NEAA, 1% glutamax).
The inoculated cells were incubated for 14 days at 37°C
in a closed flask and culture medium was refreshed twice
a week. The cell culture was negative for Chlamydia
abortus, Simkania negevensis and mycoplasma. A large
batch of strain X09003262-001 was prepared and the
mouse-infective dose (MID) of the batch was determined.
Prior to inoculation, the inoculum was adjusted to the re-
quired MID by dilution with culture medium. The strain
was genotyped as CbNL01, the predominant C. burnetii
genotype in the Dutch Q fever outbreak. To ensure in-
oculation of Phase 1 bacteria, cell culture passage 2 of
the field isolate was used. In the inoculum, no Phase 2
C. burnetii were detected with an immunofluorescence
test set up with the serum of a goat with a high anti-
Phase 2 antibody titre but no Phase 1 titre. All ex-
periments were approved by the Animal Experiment
Commission of the Central Veterinary Institute, part of
Wageningen UR, in accordance with Dutch regulations
on animal experimentation.
Animal experiment
The experimental set up has previously been described
(Experiment III, [14]). Sixteen healthy, pregnant, sero-
logically Q fever negative, Alpine yearling goats were pur-
chased from INRA (Institut National de la Recherche
Agronomique, Domaine de Galle), France. Pregnancy
and the duration of pregnancy were confirmed using
ultrasound. All goats tested serologically negative for
antibodies against C. burnetii and Chlamydia abortus on
the day of arrival. Six negative control goats were housed
in animal biosafety level (aBSL) 2 facilities. Two groups
of 5 goats (Group A and B) were separately housed in
aBSL3 facilities for inoculation with C. burnetii. On day
76 of pregnancy, 10 goats were intranasally inoculated
with 1 mL containing 106 MID C. burnetii while the six
negative control animals were intranasally inoculated
with 1 mL of culture medium. General health was moni-
tored by daily clinical inspection of behaviour, appetite
and consistency of the faeces. All goats were kept alive
until the end of the experiment at 13 weeks post inocula-
tion (wpi) (negative controls and Group A) and 14 wpi
(Group B). Weak-born kids were euthanised when neces-
sary for ethical reasons and liveborn kids were kept to-
gether with their does until the end of the experiment.
During the experiment goats did not show any clinical
signs of disease except for abortion. Three of the ten
Coxiella-inoculated goats aborted (one single kid and
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livered one stillborn kid and one liveborn weak kid at 10
wpi. Two goats delivered one stillborn and one liveborn
healthy kid each at 9 wpi; one goat delivered two weak
kids at 9 wpi and three goats delivered healthy kids, all
singles at 9 wpi. The six control goats delivered healthy
liveborn kids at 10 and 11 wpi, which was equal to 149 to
157 days of gestation. C. burnetii was detected in the
placentas of all ten Coxiella-inoculated goats by immu-
nohistochemistry and by PCR in the vaginal mucus
just after parturition. These results indicate that all
Coxiella-inoculated goats were successfully infected with
C. burnetii.
Sampling
Jugular blood was sampled from each of the goats weekly
from 0 wpi just before the inoculation until 13 wpi, ex-
cept that at 4 wpi goats were not sampled and at 13 wpi
the negative control goats were not sampled for antibody
detection for logistical reasons. When results from sam-
ples were related to parturition, parturition was set at
time point 0; results from samples taken in the week be-
fore parturition were indicated as week −1 and results
from samples taken in the week after parturition were in-
dicated as week 1. Blood was collected in coagulation
tubes for antibody detection, in anticoagulation tubes
(EDTA) for cell-mediated immunity and in PAXgeneW
Blood RNA tubes to preserve cytokine’s mRNA.
Detection of phase 1 and phase 2 IgM and IgG antibodies
C. burnetii Phase 1 and Phase 2 IgM- and IgG-specific
antibodies were detected in an ELISA format. C. burnetii
Phase 1 and Phase 2 ELISA-specific plates were pur-
chased from Virion/Serion (Serion ELISA classic Coxiella
burnetii Phase 1 and Phase 2, Germany). Optimal serum
and conjugate dilutions were determined in advance and
positive and negative controls were selected (data not
shown). Plates were incubated with 100 μL 1:160 diluted
serum in phosphate buffered saline (PBS), pH 7.2 with
0.5 ml 10% (v/v) tween 80 (PBS-Tw) for 1 h at 37°C.
After incubation, plates were washed automatically
(Schleicher, Germany), 6 times with 1400 μL of 0.5 ‰
Tween 20 in water and incubated for 1 h at 37°C with
100 μL of diluted alkaline phosphatase-conjugated anti-
bodies. For the detection of IgM antibodies rabbit anti-
goat IgM (Bioconnect, the Netherlands) antibodies were
used, 1:1000 diluted in PBS-Tw and 0.5 M NaCl for the
detection of Phase 1 antibodies or 1:5000 diluted for
the detection of Phase 2 antibodies. For the detection
of IgG antibodies rabbit F(ab’)2 anti-goat IgG (H/L)
(Bioconnect, the Netherlands) were used, 1:2000 diluted
for the detection of Phase 1 antibodies or 1:4000 diluted
for the detection of Phase 2 antibodies. After incubation
with the conjugate, plates were washed as describedabove and 100 μL of para-nitrophenylphosphate sub-
strate (Virion/Serion, Germany) per well was added and
the reaction was stopped after 30 min at 37°C with
100 μL of 1.2 N sodium hydroxide (Virion/Serion,
Germany). The optical density (OD) was measured at
405 nm (EL 808 Ultra microplate reader, Bio-tek instru-
ments, USA). On each plate the same negative and posi-
tive control serum was tested in duplicate per phase/Ig
combination. Results of the serum were given related to
the average positive control OD, both corrected for the
average negative control OD.
Interferon-gamma, enzyme-linked, immunosorbent spot
test (IFN-γ Elispot)
Peripheral blood mononuclear cells (PBMCs) were isolated
from EDTA blood by Ficoll-Hypaque (Amersham Biosci-
ences, Sweden) density gradient centrifugation. Interferon-
gamma, enzyme-linked immunosorbent spot test (IFN-γ
Elispot) assay was performed using 5 × 105 PBMCs per
well (MSIPS4W10 plates, Millipore, USA) from each goat.
Detection of the T cell-produced IFN-γ was performed with
the Elispot kit for Bovine/Ovine/Equine IFN-γ (MabTech,
Nacka Strand, Sweden). We evaluated the kit for caprine
IFN-γ and found it suitable for use (data not shown). C.
burnetii T-cell responses were examined after stimulation
with culture medium (negative control), C. burnetii strain
Nine Mile Phase 1 and Phase 2 (Virion/Serion 1227, 1:5000
diluted in culture medium) or ConA (positive control).
IFN-γ spot-forming cells were counted using an Immuno-
Spot analyzer (CTL, USA). We optimised counting param-
eters to precisely and accurately count all Elispot plates.
The average results of all goats in the group are given as
relative results of the positive control after correction for
the medium control.
Lymphocyte proliferation test (LPT)
PBMCs suspended in medium (negative control), C. burnetii
strain Nine Mile Phase 1 and Phase 2 (Virion/Serion
1227, 1:5000 diluted in culture medium) or ConA
(positive control) were added to triplicate wells. Plates
were incubated at 37°C for 72 h. For the last 18 h of
incubation, alamar blue (Invitrogen, USA) was added.
Supernatant was harvested and absorbance was mea-
sured at 570 nm/600 nm. Results are given as average re-
sults per group. Individual results were calculated as
relative induction of the average difference of the OD at
600 nm and 570 nm of the sample in duplicate compared
to the medium control.
Cytokine mRNA induction
Blood specimens (2.5 mL) collected in PAXgeneW tubes
were incubated at room temperature for 4 h for RNA sta-
bilisation and then stored at −80°C. RNA was extracted
from whole blood using the manufacturer’s guidelines. In
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over night at 4°C to ensure complete lysis of the blood
cells. Then tubes were centrifuged for 10 min at 4000 g,
the supernatant was discarded and 5 mL of RNase-free
water was added to the pellet. The pellet was resuspended.
Washing was repeated and the pellet was finally resus-
pended in 1 mL trizol (Invitrogen, USA). Subsequently,
a phase separation with chloroform was performed and
RNA was precipitated using 2-propanol. Additional purifi-
cation was performed with the DNA-free kit (Ambion,
USA). The quality and integrity of the RNA samples were
analysed using the Agilent Bioanalyzer (lab on chip,
Agilent Technologies, USA). For the quantification of cy-
tokine mRNA, cDNA was made using random hexamer
primers and reverse transcriptase. Forward and reverse
primers were selected to detect the cDNA of TNF-α, IL-
1β, IFN-α, IFN-γ, IL-2 and IL-10 (Table 1). PCR was
performed using Syber Green PCR Master Mix (Applied
Biosystems, USA) in an ABI 7500 Real-Time PCR system
(PE Applied Biosystems, USA). Results were quantified
and normalised compared to the amount of succinate de-
hydrogenase complex subunit A gene (SDHA) of the same
sample. SDHA was selected as reference gene on basis of
the geNORM Bos Taurus housekeeping gene selection kit
(Primerdesign, UK) as the best performing housekeeping
gene compared to the other housekeeping genes included
in the kit. For the quantification, a standard curve of the
plasmid with the insert of the cytokine of interest con-
structed in pGEM-T easy (Promega, the Netherlands) was
used. For the determination of the amount of the refer-
ence gene per sample, a standard curve of mRNA SDHA
in water was used. For negative controls, RNA samples
without reverse transcriptase in the reaction mixture
were used.Table 1 Sequences of the forward en reverse primers
used to detect the DNA transcripts of the mRNA of goat’s
TNF-α, IL-1β, IFN-α, IFN-γ, IL-2 and IL-10
Gene of interest NCBI code Primer Sequence
TNF-α X14828 Forward CCTTGAGAAGATCTCACCTA
Reverse CAAACATAAACAGAGGGAGT
IL-1β DQ837160 Forward TACCTGTCTTGTGTGAAAAA
Reverse CAAATTCAACTGTGTTCTTG
IFN-α FJ959074 Forward GAGGAAATACTTCCACAGAG
Reverse ATGACTTCTGCTCTGACAAC
IFN-γ EF375708 Forward GAAATTTTGAAGAATTGGAA
Reverse AATGACCTGGTTATCTTTGA
IL-2 AF535145 Forward GATGTCTAGAAGCAAGGGTA
Reverse ACATCCAAATGAGTTCTGTT
IL-10 DQ837159 Forward GGCAAAGTGAAGACTTTCT
Reverse ACTGGATCATTTCTGACAAG
NCBI National Center for Biotechnology Information.Statistical analyses
A two-way analysis of variance (ANOVA) with infection
status (i.e. infected with C. burnetii and non-infected
goats) and sample week as independent variables and the
results of the used tests (i.e. phase specific ELISAs, IFN-γ
Elispot, LPT and the different cytokines) as dependent
variable was used to compare the difference between de
parameters of the two groups of animals (IBM SPSS Statis-
tics 19). Homogeneity of variances was preliminary tested
using Levene’s test. P values ≤ 0.05 correspond with a con-
fidence interval of 95%, marked as *; P ≤ 0.01 correspond
with a confidence interval of 99%, marked as **.
Results
Humoral immune response
Ten pregnant goats were intranasally inoculated with a
Dutch C. burnetii outbreak strain and jugular blood was
sampled weekly. The serum of each goat was tested for
IgM and IgG C. burnetii-specific antibodies using C.
burnetii Phase 1- and Phase 2-specific ELISAs. Average
IgM antibody levels against Phase 2 antigen (IgMph2)
rised significantly from three weeks post-inoculation (wpi)
onwards; after 3 wpi the antibody titre decreased and
stabilised until the end of the experiment (Figure 1a). Aver-
age anti-C. burnetii Phase 2 IgG antibody levels (IgGph2)
rapidly increased between 2 wpi and 4 wpi and then at a
slower rate till 10 wpi (Figure 1b). Average anti-C. burnetii
Phase 1 IgM antibody levels (IgMph1) started to rise from
3 wpi onwards and a significant difference between the
infected and non-infected group was present at 4 wpi and
from 8 wpi till the end of the experiment (Figure 1c). Anti-
C. burnetii Phase 1 IgG antibody levels (IgGph1) started to
rise at 6 wpi; at 9 wpi the average titre stabilised until the
end of the experiment at 12 wpi (Figure 1d). IgMph2 and
IgGph2 levels were not influenced by parturition. The sec-
ond rise of IgMph1 started 1 week before parturition.
IgGph1 started to rise 4 weeks before parturition. The data
indicate a strong IgMph2 and IgGph2 response starting
after two weeks after inoculation. The IgMph1 and IgGph1
response started later after inoculation.
Cell-mediated immune response
To investigate the cell-mediated immune response,
IFN-γ Elispot and the LPT were performed on cells
isolated from the jugular blood samples. In these tests
C. burnetii Phase 1 and Phase 2 antigens were used as
stimulus. In the first four weeks after inoculation, no sig-
nificant difference between the Coxiella-inoculated goats
and the control goats was observed in the IFN-γ produc-
tion by peripheral blood mononuclear cells (PBMCs)
after stimulation with C. burnetii Phase 1 and Phase 2
antigen (Figure 2a).
More detailed analysis of the IFN-γ Elispot results re-
vealed a strong increase of the IFN-γ producing PBMCs
Figure 1 Results of the C. burnetii phase 1 and phase 2 IgM and IgG specific ELISA. Average antibody titres expressed as S/P ratio corrected
for the negative control for IgM Phase 2 (IgMph2, ♦, A) and Phase 1 (IgMph1,▲, C) and IgG Phase 2 (IgGph2, ●, B) and Phase 1 (IgGph1, ■, D)
as measured with an IgM- and IgG- specific conjugate in C. burnetii phase-specific ELISA. (−): negative control goats *: P ≤ 0.05; **: P ≤ 0.01.
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lated goats and control goats. Upon correcting for the
date of parturition, the increase in IFN-y production in
both Coxiella-inoculated and control goats corresponded
to the time of parturition (Figure 2b), suggesting thatFigure 2 IFN-y Elispot results, related to inoculation and to parturitio
antigen. Data were corrected for medium-incubated cells and expressed as
inoculation. Solid bar: delivery period of the Coxiella-inoculated goats; dotte
(■) Coxiella-inoculated goats; (−) negative control goats; *: P ≤ 0.05; **: P ≤parturition influences IFN-y production in goats. In the
further analysis of the IFN-γ Elispot and LPT results,
data were corrected for parturition. Stimulation with
both Phase 1 and Phase 2 antigen resulted in a significant
increase of the production of IFN-γ one week aftern. Average data for PBMCs stimulated with Phase 1 and Phase 2
a percentage of ConA-stimulated cells. A: data were related to
d bar: delivery period of the control goats. B: data related to delivery.
0.01.
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crease in proliferation ability of the PBMCs only after
parturition in the Coxiella-inoculated goats (Figure 4a
and b). The increase in proliferation ability after stimula-
tion with C. burnetii Phase 2 antigen was stronger com-
pared to stimulation with Phase 1 antigen (Figure 4b).
Taken together, no clear cell-mediated immune response
could be detected in the first weeks after infection. Only
after parturition a significant increase in cell-mediated
immune response was measured.
Systemic cytokine mRNA responses
Additional information about the cellular and humoral
immune response was obtained via weekly measurement
of systemic mRNA levels of the regulation of the pro-
inflammatory cytokines TNF-α and IL-1β and the regu-
latory cytokines IL-2 and IL-10. IFN-α and IFN-γ mRNA
regulation was measured likewise. Within 4 weeks after
inoculation no differential effect on cytokine mRNA
levels was measured between the Coxiella-inoculated
group compared to the control group (data not shown).
Systemic cytokine responses related to parturition are
presented in Figure 5. The pro-inflammatory cytokines
TNF-α and IL-1β mRNA were up regulated after partur-
ition compared to the non-infected goats. No effect
could be observed on IFN-α- and IFN-γ mRNA levels.
For the regulatory cytokines IL-2 and IL-10 mRNA, IL-2
was down regulated one week after parturition while IL-
10 was up regulated four and three weeks before partur-
ition (Figure 5). Results indicate a significant systematic
up regulation of TNF-α, IL-1β and IL-2 after parturition
and a up regulation of IL-10 before parturition in the
Coxiella-inoculated goats compared to the control goats.
Discussion
The goal of this experimental longitudinal study was to
investigate the humoral and cellular immune responsesFigure 3 IFN-y Elispot results, per C. burnetii phase 1 and phase 2 stim
and Coxiella-inoculated goats after stimulation with C. burnetii Phase 1 or P
expressed as percentage of ConA-stimulated cells, the X-axis is in weeks re
C. burnetii Phase 1 antigen, (▲: C. burnetii-inoculated goats; −: control goat
(●: C. burnetii-inoculated goats; −: control goats); *: P ≤ 0.05; **: P ≤ 0.01.in pregnant goats infected via a natural infection route
with a Dutch outbreak isolate of C. burnetii. The im-
mune response after C. burnetii inoculation via inhal-
ation in domestic ruminants had not been studied yet.
This inoculation route was successful in infecting goats
and resulted in C. burnetii-infected placentas [14]. Up
until now only subcutaneous inoculations had been used
to study humoral immune responses [20,21]. However,
the inoculation route might be important for studying
naturally occurring immune responses.
Our results indicate a strong IgM anti-Phase 2 and
IgG anti-Phase 2 humoral response, which starts to rise
between 2 to 3 weeks post inoculation. This time period
between inoculation and the first antibody response is
shorter than reported for non-phase-specific antibodies
in goats after subcutaneous inoculation [20,21], but is
slightly longer than reported for humans and mice
[22,23]. For goats, the difference with previous studies
may be due to the use of different inoculation routes. In-
oculation via inhalation can generate a mucosal immune
response in the lungs; in humans, the lungs have the
ability to respond quickly to some pathogens, i.e.
Streptococcus pneumoniae. In the lungs, residential
antigen-specific memory B cells are present but it is also
reported that infections in the lung generate a de novo
local and systemic antibody response [24]. In goats it is
not known whether C. burnetii can induce such a re-
sponse in the lung but the fast systemic antibody re-
sponse could be a result of this.
The initial humoral immune response consisted of the
generation of C. burnetii Phase 2-specific antibodies,
whereas antibodies against C. burnetii Phase 1 arose at a
later stage. Although in line with previously published
work in mice, guinea pigs and humans [22,23,25], it is
not clear why an anti-Phase 2 response is generated in
advance of an anti-Phase 1 response, as Phase 1 Coxiella
bacteria were inoculated. One possible explanation isulus, related to parturition. Results of the PBMC of control goats
hase 2 antigen. Data were corrected for medium-incubated cells and
lated to parturition (time point 0). A: results after stimulation with
s). B: results after stimulation with C. burnetii Phase 2 antigen
Figure 4 LPT results, per C. burnetii phase 1 and phase 2 stimulus, related to parturition. Lymphocyte proliferation test results of the
control goats and Coxiella-inoculated goats. Data are expressed as average results of the group in fold induction compared to medium-incubated
cells. The X-axis indicates weeks related to parturition (time point 0). A: results after stimulation with C. burnetii Phase 1 (▲: C. burnetii-inoculated
goats; −: control goats). B: results after stimulation with C. burnetii Phase 2 antigen (●: C. burnetii-inoculated goats; −: control goats); *: P ≤ 0.05;
**: P ≤ 0.01.
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inoculated as well. Phase 2 bacteria are efficiently inter-
nalised into phagosomes [9,26]. This results in an effec-
tive killing of the Phase 2 bacteria that gives rise to a
humoral response against Phase 2 C. burnetii. Alterna-
tively, it can be assumed that both LPS and surface pro-
tein antigens of Phase 1 C. burnetii are recognised by
the immune system but that surface proteins, which
Phase 1 and Phase 2 C. burnetii have in common [27],Figure 5 Results of the systemic cytokine mRNA response detected b
the blood of Coxiella-inoculated goats normalised to SDHA in the period a
was examined in Coxiella-inoculated goats and in control goats every week
period. Triangles represent the data of individual Coxiella-inoculated goats.
point. Significant elevation of the systemic mRNA levels between Coxiella-in
** for P ≤ 0.01.give an earlier and stronger humoral immune response
compared to the LPS antigen. This results first in an
anti-Phase 2 response to the surface antigens, followed
by an anti-Phase 1 response against LPS. As we were not
able to detect Phase 2 C. burnetii in our inoculum, we
assume that both surface proteins and LPS are detected
by the immune system. Therefore the initial anti-Phase 2
response may be due to an earlier and stronger response
to surface proteins than to LPS.y qPCR. The results show cytokine mRNA levels measured by qPCR in
round parturition. The presence of cytokine mRNA in peripheral blood
post inoculation but no differences were found until the displayed
The horizontal line represents the mean of the group at that time
oculated and control goats is indicated as * for P ≤ 0.05 and
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started to rise at almost the same time. This was not
expected, as IgM is generally the first immunoglobulin
class to be produced in a humoral immune response be-
cause IgM can be expressed without class switching.
During human Coxiella infection, IgM anti-Phase 2
antibody titres also start to rise first followed by a IgG anti-
Phase 2 response [22]. The phase-specific and antibody-
subclass-specific humoral immune response might help
in the detection of early or more prolonged C. burnetii
infections in goats. As pregnant goats do not excrete the
bacterium [14] the detection of anti-Phase 2 IgM without
anti-Phase 1 IgG will indicate an early infection. Whether
phase-specific and antibody-subclass-specific antibody titres
can predict or indicate chronic infections in goats should
be investigated in further research, as the study period in
the present study was only 13 weeks.
The cell-mediated immune response during the first
weeks after inoculation was minimal, as indicated by the
results of the IFN-γ Elispot and the apparent absence of
a systemic cytokine mRNA responses. This might indi-
cate that the PBMCs have not been in contact with
C. burnetii. This corresponds with our earlier results,
which showed that Coxiella bacteria were not detectable
in the blood after inoculation despite the infection of the
trophoblasts of the placenta between 2 and 4 weeks after
inoculation [14]. Studies in non-pregnant mice indicate
that IFN-γ has a role in the early control of C. burnetii
proliferation [12]. This is probably not true in pregnant
goats because we were not able to detect an increase in
IFN-γ producing cells in the weeks after inoculation.
Therefore IFN-γ probably does not play a role in
preventing C. burnetii replication in the early stages of
infection in pregnant goats.
Cell-mediated immune responses were first detected
in the first week after parturition. At the time of partur-
ition, the C. burnetii DNA load in the tissues is maximal
as previously shown [14], resulting in exposure to the
systemic immune system. This exposure coincides with
an up regulation of the pro-inflammatory cytokines
TNF-α and IL-1β. This probably caused the strong in-
crease in the total production of IFN-γ by PBMCs at
one week post parturition and the increase of the prolif-
eration ability of PBMCs. However, parturition in non-
infected goats also coincided with an increase in IFN-γ
producing PBMCs as measured in the control goats.
This could be an effect of the release of suppression of
the cell-mediated immune response after parturition.
During pregnancy progesterone levels are high and de-
crease shortly before parturition [28]. In humans it is
suggested that high progesterone levels are associated
with a Th-2 type immunity, resulting in an increased
humoral immune response and a decreased cell-mediated
immune response [29]. In pregnant goats we also assumea down regulation of the cell-mediated immune re-
sponse due to progesterone during pregnancy. If the
suppression is alleviated after parturition, a strong in-
crease in IFN-γ producing cells can be expected. Over-
all, we assume that two mechanisms probably influence
the cell-mediated immune response in Coxiella-infected
pregnant goats, i.e. a stimulation by the release of
Coxiella antigens and a suppression of cell-mediated im-
munity due to progesterone, with the overall effect that
in infected goats no cell-mediated immune response was
found during pregnancy.
IL-10 was up regulated towards the end of pregnancy
in the Coxiella-inoculated goats. In mice as well as in
humans persistent Coxiella presence seems to be IL-10
dependent [9,30] and humans suffering from chronic Q
fever excrete high levels of IL-10 [9]. It can be
hypothised that Coxiella-infected pregnant goats may
react similar as persistently infected mice and humans
and reach a chronic infection status which is terminated
by the induction of parturition. However, little is known
about persistence of Coxiella infections in goats and
how to detect these animals. In our earlier experiments
on the pathogenesis of Q fever in pregnant goats we
were not able to detect C. burnetii DNA at 81 days after
parturition [14] although others were able to detect
C. burnetii DNA in the genital tract of non-pregnant
goats [31] and field observations may indicate long last-
ing shedding of C. burnetii in previously infected non-
pregnant dairy goats [32]. To elucidate this further
research is needed.
The results of our study may have several implica-
tions for diagnostic applications of immunological
tests for Q fever in pregnant animals. Cell-mediated
immune responses did not differ enough to distinguish
between Coxiella-infected and non-infected pregnant
goats. IFN-γ Elispot, LPT and an additional performed
IFN-γ ELISA (data not shown, as results were over all
even less discriminative) have no additional value in
the diagnosis of Q fever in pregnant goats. The strong
humoral response, however, is useful in the early de-
tection of infected pregnant goats, because these goats
cannot be diagnosed by the detection of C. burnetii
[14]. The phase-specific IgM and IgG response might
be useful in understanding the dynamics of Q fever in
a herd, as animals in different stages of infection can
be followed.
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